Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricTEVATeva Pharmaceutical Industries LtdZTSZoetisHLNHaleon PLC
Snapshot
Price$39.55$69.84$8.80
Market cap$32.95B$33.26B$40.75B
Valuation
P/E25.8x11.2x19x
Forward P/E—10.3x16.2x
Growth
Revenue growth4.4%2.4%-1.8%
EPS growth—8.4%17.6%
Profitability
Net margin9.0%27.8%15.1%
ROE20.7%62.4%10.3%
Balance sheet & cash
Debt / equity2.12x2.72x0.52x
Free cash flow yield-10.5%7.5%0.5%
Dividend yield—1.6%1.9%
Verdict
Investment ratingWeak· 33Favorable· 63Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearTEVAtoday $40ZTStoday $70HLNtoday $9
2027$30.97 – $45.42+15% CAGR$56.77 – $83.27+19% CAGR$7.76 – $11.38+29% CAGR
2028$32.34 – $47.43+10% CAGR$61.54 – $90.26+14% CAGR$9.12 – $13.38+23% CAGR
2029$33.76 – $49.52+8% CAGR$66.70 – $97.83+12% CAGR$10.73 – $15.73+21% CAGR
2030$35.25 – $51.70+7% CAGR$72.30 – $106.04+11% CAGR$12.61 – $18.50+20% CAGR
2031$36.81 – $53.98+6% CAGR$78.36 – $114.93+10% CAGR$14.83 – $21.74+20% CAGR
5-yr CAGR-1.4% – 6.4%2.3% – 10.5%11.0% – 19.8%